Milestone Capital China
31
16M
29
13
0.06
9
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Shanghai. The company was established in Asia in China.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Comics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight ASLAN Pharmaceuticals, Focus Media, Suzhou Xiexin Photovoltaic Technology Co., Ltd. The fund has specific favorite in a number of founders of portfolio startups.
We also calculated 7 valuable employees in our database.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Milestone Capital China, startups are often financed by Sagamore Bioventures, Morningside Group, Cenova Ventures. The meaningful sponsors for the fund in investment in the same round are CDH Investments, WI Harper Group, United Capital Investment Group Limited. In the next rounds fund is usually obtained by Sanofi, Yunli Lou, VT Ventures.
The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2018. When the investment is from Milestone Capital China the average startup value is 10-50 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. This Milestone Capital China works on 9 percentage points less the average amount of lead investments comparing to the other organizations.
Investments analytics
Analytics
- Total investments
- 31
- Lead investments
- 13
- Exits
- 9
- Follow on index
- 0.06
- Investments by industry
- Health Care (5)
- Biotechnology (5)
- Manufacturing (4)
- Medical (4)
- Pharmaceutical (4) Show 51 more
- Investments by region
-
- China (26)
- Taiwan (2)
- Singapore (1)
- United States (1)
- Peak activity year
- 2014
- Number of Unicorns
- 1
- Number of Decacorns
- 2
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 103M
- Group Appearance index
- 0.48
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.84
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
ChainNews | 29 May 2019 | News, Blockchain | Seed | 0 | China, Beijing, Dongcheng District |
Limefy Inc. | 25 Nov 2015 | Event Management, Events, Wearables | Seed | 25K | United States, Washington, Sammamish |
PrinJohnson BioPharm | 01 Jun 2014 | Early Stage Venture | Shanghai, Shanghai, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.